Apogee Therapeutics Azioni (NASDAQ: APGE)

Apogee Therapeutics (NASDAQ:APGE) Azioni

APOGEE THERAPEUTICS INC

Apogee Therapeutics

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Apogee Therapeutics Inc

Earnings

Earnings Beats

Earnings Misses

News

Lennar Q2 Adj. EPS $1.81 Misses $1.94 Estimate, Sales $8.38B Beat $8.16B Estimate

Viper Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNOM#NASDAQ">VNOM</a>) has outperformed the market over the past 5 years by 15.6% on an annualized basis producing an average annual return of 29.92%. Currently, Viper Energy has a market capitalization of $5.62 billion. 
Buying $100 In VNOM: If an investor had bought $100 of VNOM stock 5 years ago, it would be worth $362.38 today based on a price of $42.86 for VNOM at the time of writing.
<h3>Viper Energy's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750110318_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

VNOM

$100 Invested In Viper Energy 5 Years Ago Would Be Worth This Much Today

<a href="https://www.bloomberg.com/news/articles/2025-06-16/trump-says-russia-sanctions-would-cost-us-a-lot-of-money">https://www.bloomberg.com/news/articles/2025-06-16/trump-says-russia-sanctions-would-cost-us-a-lot-of-money</a>

General

'Trump Says Russia Sanctions Would Cost US 'A Lot of Money'- Bloomberg

Management

On June 15, 2025, FrontView REIT Terminated Randall Starr As Co-CEO, CFO, Treasurer, And Secretary, Effective Immediately; Sean Fukumura Appointed Interim CFO, Treasurer, And Secretary

Offerings

MMYT

MakeMyTrip Files For Offering Of 14M  Ordinary Shares

Stock Split

XXII

22nd Century Group Authorizes 1-For-23 Reverse Stock Split; Reverse Stock Split To Restore Nasdaq Listing Compliance

Allison Transmission (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALSN#NYSE">ALSN</a>) has outperformed the market over the past 10 years by 1.15% on an annualized basis producing an average annual return of 12.16%. Currently, Allison Transmission has a market capitalization of $8.13 billion. 
Buying $100 In ALSN: If an investor had bought $100 of ALSN stock 10 years ago, it would be worth $313.33 today based on a price of $95.41 for ALSN at the time of writing.
<h3>Allison Transmission's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750109422_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALSN

Here's How Much You Would Have Made Owning Allison Transmission Stock In The Last 10 Years

KAVL

Kaival Brands Innovations Group Files For Mixed Shelf Offering Of Up To $100M

<a href="https://www.bloomberg.com/news/articles/2025-06-16/trump-ishiba-meet-at-g-7-as-japanese-leader-seeks-trade-deal">https://www.bloomberg.com/news/articles/2025-06-16/trump-ishiba-meet-at-g-7-as-japanese-leader-seeks-trade-deal</a>

'Trump, Ishiba Meet at G-7 as Japanese Leader Seeks Trade Deal'- Bloomberg

CRWS

Crown Crafts Craig J. Demarest Retiring As CFO Effective June 30, 2025; Claire K. Spencer Appointed As New CFO Effective June 30, 2025

Micron Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) has outperformed the market over the past 10 years by 6.2% on an annualized basis producing an average annual return of 17.21%. Currently, Micron Technology has a market capitalization of $133.89 billion. 
Buying $1000 In MU: If an investor had bought $1000 of MU stock 10 years ago, it would be worth $4,865.61 today based on a price of $119.80 for MU at the time of writing.
<h3>Micron Technology's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750108512_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In Micron Technology 10 Years Ago Would Be Worth This Much Today

PURE Bioscience (OTC:<a class="ticker" href="https://www.benzinga.com/stock/PURE#OTC">PURE</a>) reported quarterly losses of $(0.01) per share. This is unchanged from the same period last year. The company reported $491.00 thousand in sales this quarter. This is a 11.34 percent increase over sales of $441.00 thousand the same period last year.

PURE

PURE Bioscience Q3 EPS $(0.01), Same YoY, Sales $491.00K Up From $441.00K YoY

Highlights:
<ul>
<li>70,000 metres ("m") diamond drill program underway;</li>
<li>Approximately 11,750 m in 104 DDH1&nbsp;has been drilled to date, with five drill rigs currently on site;</li>
<li>80% of planned drilling focused on resource definition and pre-development work and 20% on exploration;</li>
<li>The AFZ Core excavation program is underway, with channel sampling of the Iceberg excavation approximately 80% complete and the Lotto excavation commencing shortly;</li>
<li>A regional exploration program at Queensway South and Queensway North is underway and is expected to run until late September, 2025;</li>
<li>In addition to a PEA2&nbsp;planned for release in late Q2/25, the Company is conducting ongoing engineering studies, including metallurgical testwork and trade-off studies; and</li>
<li>Additional environmental work will be undertaken in 2025 to ensure that all baseline studies are completed for upcoming permitting processes.</li>
</ul>

NFGC

New Found Gold To Expand Queensway Gold Project 2025 Work Program

BriaCell Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCTX#NASDAQ">BCTX</a>) reported quarterly losses of $(1.64) per share. This is a 201.86 percent decrease over earnings of $1.61 per share from the same period last year.

BCTX

BriaCell Therapeutics Q3 EPS $(1.64) Down From $1.61 YoY

ANET

On June 13, 2025, Arista Networks Appointed Todd Nightingale As President And COO; Mr. Nightingale Will Join The Company On Or About July 1, 2025

LGCB

Linkage Global Files Registration Statement For Resale Of 4M Class A Shares By Selling Shareholders

Redwire Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDW#NYSE">RDW</a>) shares are falling in Monday&#8217;s after-hours session after the company announced a <a href="https://www.benzinga.com/pressreleases/25/06/b45961268/redwire-announces-offering-of-200-000-000-of-common-stock">common stock offering</a>. 
What Happened: After the market close on Monday, Redwire announced that it commenced a $200 million registered public offering of common stock. The company plans to grant the underwriters a 30-day option to purchase up to an additional 15% of shares sold in the offering. 
Redwire expects to use the net proceeds for general corporate purposes, including to fund growth, to repurchase a portion of its stock and to repay the previously disclosed seller note issued in connection with its acquisition of Edge Autonomy.
Redwire announced the closing of its Edge Autonomy acquisition on Friday. The deal included $160 million in cash and $765 million in stock, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Redwire had $89.2 million of total liquidity as of March 31, which included $54.2 million in cash and cash equivalents and $35 million in available borrowings from existing credit facilities.
<h1 class="wp-block-heading">How To Buy RDW Stock</h1>
By now, you're likely curious about how to participate in the market for Redwire, be it to purchase shares or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option or sell a call option at a strike price above where shares are currently trading — either way, it allows you to profit from the share price decline.
RDW Price Action: <a href="http://benzinga.com/quote/rdw">Redwire shares</a> were down 10.55% in after-hours Monday, trading at $18.40 at the time of publication, per <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/earnings/25/06/45961553/digital-turbine-stock-climbs-after-better-than-expected-q4-report-details">Digital Turbine Stock Climbs After Better-Than-Expected Q4 Report: Details</a></li>
</ul>
Photo: <a href="https://www.shutterstock.com/g/Timon+photography+world">T. Schneider</a>/Shutterstock.

SPACE

After-Hours Center

Movers

Redwire Stock Is Tumbling After Hours: Here's Why

<h3>Gainers</h3>
<ul>
<li>INNEOVA Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INEO#NASDAQ">INEO</a>) shares rose 42.3% to $1.58 during Monday's after-market session. The company's market cap stands at $15.6 million. </li>
<li>Vince Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VNCE#NYSE">VNCE</a>) shares moved upwards by 9.52% to $1.84. The market value of their outstanding shares is at $23.2 million. </li>
<li>Springview Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPHL#NASDAQ">SPHL</a>) shares moved upwards by 8.52% to $0.53. The company's market cap stands at $6.1 million. </li>
<li>ZSPACE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZSPC#NASDAQ">ZSPC</a>) stock increased by 7.58% to $3.97. The market value of their outstanding shares is at $90.8 million. </li>
<li>Vasta Platform (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSTA#NASDAQ">VSTA</a>) shares moved upwards by 6.23% to $4.6. The company's market cap stands at $368.7 million. </li>
<li>SharpLink Gaming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBET#NASDAQ">SBET</a>) shares rose 5.74% to $14.18. The company's market cap stands at $9.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Fitell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTEL#NASDAQ">FTEL</a>) shares fell 14.3% to $0.47 during Monday's after-market session. The company's market cap stands at $9.3 million. </li>
<li>MKDWell Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKDW#NASDAQ">MKDW</a>) stock fell 7.24% to $0.27. The market value of their outstanding shares is at $38.1 million. </li>
<li>Greenlane Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares declined by 5.65% to $0.01. The company's market cap stands at $11.9 million. </li>
<li>Ruanyun Edai Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYET#NASDAQ">RYET</a>) stock decreased by 4.88% to $7.31. The market value of their outstanding shares is at $246.7 million. </li>
<li>ZHONGCHAO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZCMD#NASDAQ">ZCMD</a>) stock fell 4.73% to $1.21. The market value of their outstanding shares is at $30.5 million. </li>
<li>Worksport (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WKSP#NASDAQ">WKSP</a>) stock decreased by 4.71% to $3.04. The company's market cap stands at $15.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FTEL

GNLN

INEO

MKDW

RYET

SBET

SPHL

VNCE

VSTA

WKSP

ZCMD

ZSPC

12 Consumer Discretionary Stocks Moving In Monday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Salarius Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLRX#NASDAQ">SLRX</a>) shares moved upwards by 53.0% to $0.98 during Monday's after-market session. The company's market cap stands at $2.0 million. </li>
<li>Dyne Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYN#NASDAQ">DYN</a>) shares rose 12.15% to $15.5. The company's market cap stands at $1.7 billion. </li>
<li>Clene (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLNN#NASDAQ">CLNN</a>) shares rose 8.59% to $4.8. The company's market cap stands at $43.1 million. </li>
<li>SS Innovations (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSII#NASDAQ">SSII</a>) shares increased by 8.02% to $3.5. The company's market cap stands at $677.6 million. </li>
<li>DIH Holding US (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DHAI#NASDAQ">DHAI</a>) shares moved upwards by 7.92% to $0.23. The company's market cap stands at $11.0 million. </li>
<li>BioSig Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSGM#NASDAQ">BSGM</a>) stock rose 6.3% to $6.58. The company's market cap stands at $179.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>China Pharma Holding (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CPHI#AMEX">CPHI</a>) stock fell 8.5% to $1.69 during Monday's after-market session. The market value of their outstanding shares is at $5.5 million. </li>
<li>Geovax Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOVX#NASDAQ">GOVX</a>) stock declined by 8.34% to $1.21. The company's market cap stands at $18.3 million. </li>
<li>Helius Medical Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSDT#NASDAQ">HSDT</a>) shares declined by 7.86% to $0.35. </li>
<li>Catheter Precision (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VTAK#AMEX">VTAK</a>) stock declined by 7.22% to $0.32. The company's market cap stands at $4.0 million. </li>
<li>Alaunos Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCRT#NASDAQ">TCRT</a>) stock fell 7.22% to $2.96. The market value of their outstanding shares is at $4.8 million. </li>
<li>Applied DNA Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APDN#NASDAQ">APDN</a>) stock decreased by 6.65% to $4.78. The market value of their outstanding shares is at $2.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

APDN

BSGM

CLNN

CPHI

DHAI

GOVX

HSDT

SLRX

SSII

TCRT

VTAK

12 Health Care Stocks Moving In Monday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>BGSF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BGSF#NYSE">BGSF</a>) stock increased by 103.5% to $8.18 during Monday's after-market session. The market value of their outstanding shares is at $90.8 million. </li>
<li>Hyperscale Data (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GPUS#AMEX">GPUS</a>) shares moved upwards by 6.86% to $2.18. The company's market cap stands at $6.1 million. </li>
<li>Energys Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENGS#NASDAQ">ENGS</a>) shares increased by 5.74% to $1.84. The company's market cap stands at $26.2 million. </li>
<li>Founder Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGL#NASDAQ">FGL</a>) shares increased by 5.52% to $0.95. The market value of their outstanding shares is at $18.4 million. </li>
<li>Robin Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RBNE#NASDAQ">RBNE</a>) stock moved upwards by 5.07% to $5.78. The company's market cap stands at $13.7 million. </li>
<li>Graphjet Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTI#NASDAQ">GTI</a>) shares increased by 4.86% to $0.08. The market value of their outstanding shares is at $11.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>CDT Envirn Tech Inv Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDTG#NASDAQ">CDTG</a>) stock declined by 21.7% to $1.08 during Monday's after-market session. The company's market cap stands at $13.3 million. </li>
<li>Sunrun (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>) shares declined by 18.13% to $7.9. The market value of their outstanding shares is at $1.8 billion. </li>
<li>Redwire (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDW#NYSE">RDW</a>) shares fell 10.8% to $18.35. The company's market cap stands at $1.4 billion. </li>
<li>Icon Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICON#NASDAQ">ICON</a>) shares declined by 9.14% to $2.09. The company's market cap stands at $4.5 million. </li>
<li>Aeries Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AERT#NASDAQ">AERT</a>) shares fell 9.13% to $0.9. The company's market cap stands at $40.0 million. </li>
<li>Shoals Technologies Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHLS#NASDAQ">SHLS</a>) stock decreased by 8.42% to $4.9. The company's market cap stands at $819.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Advanced Environmental Recycling Technologies

AERT

BGSF

CDTG

ENGS

GPUS

ICON

RBNE

SHLS

12 Industrials Stocks Moving In Monday's After-Market Session

Press Releases

Apogee Therapeutics to Participate at the Guggenheim SMID Cap Biotech Conference

Apogee Therapeutics Announces First Patient Dosed in Part B of Phase 2 APEX Trial of APG777 in Patients with Moderate-to-Severe Atopic Dermatitis

Apogee Therapeutics to Participate in Upcoming March Investor Conferences

Apogee Therapeutics to Host Conference Call to Report Interim Results from the Phase 1 Healthy Volunteer Trial for APG990 and Provide Combination Strategy Update on March 3, 2025

Apogee Therapeutics Announces Positive Interim Phase 1 Results from the APG990 Healthy Volunteer Trial, Unlocking Potential Maintenance Dosing Every Three and Six Months for APG279 (APG777 + APG990)

Apogee Therapeutics Provides Pipeline Progress and Reports Full Year 2024 Financial Results

Apogee Therapeutics to Participate at the Bank of America 2025 Health Care Conference

Health Care

Apogee Therapeutics Announces Positive Interim Results from the Phase 1b Trial of APG808, its Novel Half-life Extended IL-4Rα Antibody, in Patients with Mild-to-Moderate Asthma

Apogee Therapeutics Provides Business Update, Pipeline Progress and Reports First Quarter 2025 Financial Results

Apogee Therapeutics to Participate at the Jefferies Global Healthcare Conference

Comments

Apogee Therapeutics

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO